Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.

scientific article

Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/HYPERTENSIONAHA.110.169060
P698PubMed publication ID21321303

P2093author name stringA H Jan Danser
Ingrid M Garrelds
Joep H M van Esch
Richard van Veghel
Frank Leijten
Angelique M Bouhuizen
P2860cites workqBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR dataQ29616810
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)852-858
P577publication date2011-02-14
P1433published inHypertensionQ5958695
P1476titleHandle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.
P478volume57

Reverse relations

cites work (P2860)
Q48048035(Pro)Renin receptor regulates potassium homeostasis through a local mechanism
Q39148590(Pro)renin receptor is required for prorenin-dependent and -independent regulation of vacuolar H⁺-ATPase activity in MDCK.C11 collecting duct cells.
Q34387893(Pro)renin receptor triggers distinct angiotensin II-independent extracellular matrix remodeling and deterioration of cardiac function.
Q36114245ANG II-independent prorenin/(pro)renin receptor signaling pathways in the central nervous system
Q47350464Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice
Q40067806Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR.
Q26849212Autophagy and the (Pro)renin Receptor
Q35108388Cardiac function and architecture are maintained in a model of cardiorestricted overexpression of the prorenin-renin receptor.
Q46533413Cardiac remodeling during and after renin-angiotensin system stimulation in Cyp1a1-Ren2 transgenic rats
Q35195660Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats
Q85092503Detrimental effects of dual ACEI-ARB therapy: is the (pro)renin receptor the culprit?
Q35596303Different effect of handle region peptide on β-cell function in different sexes of rats neonatally treated with sodium L-glutamate
Q64099385Effects of the (Pro)renin Receptor on Cardiac Remodeling and Function in a Rat Alcoholic Cardiomyopathy Model via the PRR-ERK1/2-NOX4 Pathway
Q37413271Handle Region Peptide Ameliorating Insulin Resistance but Not β Cell Functions in Male Rats Neonatally Treated with Sodium L-Glutamate
Q36992645Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension
Q38061004Key developments in renin-angiotensin-aldosterone system inhibition.
Q38020001Prorenin receptor regulates more than the renin-angiotensin system
Q35506543Role of non-classical renin-angiotensin system axis in renal fibrosis
Q39377571The (pro)renin receptor and its interaction partners.
Q36557476The (pro)renin receptor. A decade of research: what have we learned?
Q21284671The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling
Q38428278The Role of the (Pro)renin Receptor in Hypertensive Disease

Search more.